---
title: CatSci vs Scinai Immunotherapeutics Ltd.
slug_a: catsci
slug_b: scinai-immunotherapeutics
site: cro
review_signal_gate: closed
canonical_path: /compare/catsci/scinai-immunotherapeutics
---

# CatSci vs Scinai Immunotherapeutics Ltd.

Side-by-side profile data from each company listing on this directory.

## CatSci

- Profile: [/companies/catsci](/companies/catsci)

CatSci — UK-based partner for small molecule and complex synthetic medicines, offering route selection, process development, GMP drug substance manufacture and analytical services across four European and UK sites.

Services: 10. Modalities: 3. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Medicinal Chemistry
- Analytical Method Development & Validation
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Small Molecule
- Oligonucleotide
- Peptide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (IND-Enabling)
- Phase I
- Phase II
- Phase III

### Sourcing models

- Data not yet provided.

## Scinai Immunotherapeutics Ltd.

- Profile: [/companies/scinai-immunotherapeutics](/companies/scinai-immunotherapeutics)

Scinai Immunotherapeutics Ltd. — Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.

Services: 6. Modalities: 1. Indications: 3. Locations: 2. Certifications: 2. The strongest documented coverage currently appears in services (6).

### Services

- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)

### Indications

- Immunology
- Rare Disease
- Dermatology

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)